Deutsche Bank’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,500
| Closed | -$8K | – | 5755 |
|
|
2018
Q2 | $8K | Buy |
3,500
+3,100
| +775% | +$7.76K | ﹤0.01% | 5206 |
|
|
2018
Q1 | $1K | Buy |
400
+399
| +39,900% | +$1.26K | ﹤0.01% | 5357 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5359 |
|
|
2017
Q3 | $0 | Sell |
1
-400
| -100% | -$556 | ﹤0.01% | 5339 |
|
|
2017
Q2 | $0 | Hold |
401
| – | – | ﹤0.01% | 5372 |
|
|
2017
Q1 | $0 | Buy |
401
+400
| +40,000% | +$1.05K | ﹤0.01% | 5341 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5294 |
|
|
2016
Q3 | $0 | Sell |
1
-1
| -50% | -$4 | ﹤0.01% | 5541 |
|
|
2016
Q2 | $0 | Buy |
2
+1
| +100% | +$2 | ﹤0.01% | 5592 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | +$2 | ﹤0.01% | 5558 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5549 |
|
|
2014
Q1 | – | Sell |
-8
| Closed | – | – | 5947 |
|
|
2013
Q4 | $0 | Buy |
+8
| New | +$86 | ﹤0.01% | 5936 |
|
Deutsche Bank's BSPM Position: Q3 2018 in Review
Deutsche Bank sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2018, closing a stake of 3,500 shares — an estimated $8K sold.
Deutsche Bank first reported a position in BSPM in Q4 2013 and held it in 11 quarters. The position peaked at $8K in Q2 2018. 0 funds tracked by Wall St. Rank hold BSPM as of Q3 2018.
- Deutsche Bank reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
- Deutsche Bank sold 3,500 Biostar Pharmaceuticals, Inc. shares in Q3 2018, an estimated $8K.
- Deutsche Bank first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2013 and held it in 11 quarters.
- Deutsche Bank's Biostar Pharmaceuticals, Inc. position peaked at $8K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2018.
Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.